Articles tagged with Skin Tumors
A study published in Nature Biotechnology found that the Sindbis virus is effective at killing tumors in mice, with varying time and injection schedules required. The virus targets tumor cells by binding to a specific receptor, making it a potential tracking device for cancer.
Researchers developed a mouse model of neurofibromatosis 1 to study brain tumor growth, finding that tumors require permissive environments. Astrocytes with both copies of the Nf1 gene lacking in surrounding cells were found to develop into tumors, highlighting the importance of location in cancer development.
Researchers have found that pomegranate fruit extract and grape polyphenol resveratrol exhibit anti-skin tumor effects by inhibiting cancer-promoting pathways. These findings suggest potential benefits for skin cancer prevention and treatment.
A randomised controlled trial found that accelerated radiotherapy improved five-year tumour control by 10% compared to standard radiotherapy, with benefits also seen in patients with laryngeal cancer. The treatment was associated with a small increase in disease-specific survival, but also more acute morbidity.
A long-term follow-up study of childhood ALL survivors found that those who did not receive brain radiation had comparable survival rates, employment, and marital rates to the general population. However, those who received brain radiation had a slight increase in death rate due to second cancer and higher unemployment rates.
Researchers at Ohio State University found that endostatin can stop Kaposi's sarcoma cells from growing new blood vessels and migrating through the body. The study suggests a controlled release of endostatin could be an effective treatment option for patients with KS.
A study published in the Journal of Vascular Interventional Radiology suggests that percutaneous radiofrequency ablation can be an effective treatment for osteoid osteomas, with all eight patients achieving complete pain relief. The use of CT fluoroscopy enhanced imaging guidance improved precision and success rates.
A combination of celecoxib and a common cream used to treat nonmelanoma skin cancer was found to be up to 35% more effective in reducing skin tumors than using the cream alone. The researchers hope to reduce side effects while increasing efficacy by exploring different treatment regimens.
A recent study by the American Association for Cancer Research found that patients with advanced melanoma expressing higher levels of melanoma-associated antigens (MAAs) experienced significantly improved survival outcomes. The study suggests that these tumors may be more responsive to immunotherapy, such as vaccines against melanoma.
Researchers found that nicotine stimulates lung epithelial cells to activate a molecular pathway promoting cell growth and survival. This activation undermines the body's natural defense mechanism against cancer. The study suggests reconsidering the risk-benefit ratio of nicotine-based quitting aids.
A study by Emory University scientists identified the MAP kinase signaling pathway as a key player in early melanoma development. The researchers found that this pathway is abnormally activated in early melanomas, but not in precancerous moles. This finding has implications for diagnosis and treatment of melanoma.
A study published in the Journal of the National Cancer Institute found that higher levels of the molecule HDM2 are associated with a better prognosis in patients with melanoma. Patients with high levels of HDM2 lived significantly longer after treatment than those with low levels, even ten years after diagnosis.
Researchers at Cedars-Sinai Medical Center found that pituitary tumor cells express abundant PPAR-gamma, a protein receptor linked to growth and metabolism. Treatment with common diabetes drug rosiglitazone effectively shrunk tumors and reduced hormone production in mice with Cushing's syndrome.
Researchers have found that topical retinoids, such as tazarotene, may be a safer alternative for preventing skin cancer in individuals at risk. The study used mice with basal cell nevus syndrome, a genetic disorder that predisposes them to developing large numbers of basal cell carcinomas.
Researchers at CWRU have developed a new cancer treatment using dual-release kinetics, which could potentially allow for more effective and safest local drug therapy. The device is designed to work in synergy with image-guided thermal ablation and aims to reduce exposure of normal tissues to drugs while increasing the dosage to the tum...
Researchers have developed a new breast cancer therapy that combines heat therapy, chemotherapy, and fat liposomes to deliver drugs directly to tumors. The treatment has shown promising results, destroying tumors and saving patients' breasts from surgical removal.
Researchers have discovered a genetic environment behind nerve-tissue tumors that lead to cancer, specifically NF-1. The study found that tumors grow in a permissive environment but are nonexistent when the environment is restrictive, offering new hope for treatment approaches.
A University of Illinois study found that sunlight and PCB exposure enhance the development of non-melanoma skin cancer on parts of the body not directly exposed to the sun. Mice exposed to both sunlight and PCBs developed tumors, while those with only PCB exposure did not.
Researchers discovered that Nox1 enzyme generates reactive oxygen molecules that trigger angiogenesis and tumor growth. Inhibiting Nox1 activity or reducing hydrogen peroxide levels may decrease cancer cell growth and increase sensitivity to chemotherapy.
Researchers at UT Southwestern Medical Center have developed a new procedure for delivering vaccines by manipulating dendritic cells in the skin, reducing production time from 10 days to just 24 hours. This breakthrough could lead to more effective cancer treatments and broader clinical applications.
Researchers have successfully treated kidney tumors using radio frequency energy, achieving a 91% tumor ablation rate and no cancer recurrences in 9 of 11 patients. The minimally invasive procedure is less expensive, safer, and easier than surgery.
A study by UC Berkeley researchers found that a specific type of soy protein called lunasin can prevent the development of skin tumors in mice. The high dose group showed a 70% lower incidence of tumors compared to the control group, with fewer tumors per mouse and a two-week delay in appearance.
Researchers at the University of Florida have developed a new radiation-targeting system that uses advanced imaging and optic guidance techniques to precisely target tumors. The system, now commercially available, aims to minimize damage to surrounding healthy tissues and potentially improve cure rates.
Researchers at Yale University have found that combining Salmonella injections with radiation therapy can effectively suppress tumor growth, prolonging the life of mice by six times. The study suggests this combination therapy could be a future use for Salmonella in cancer treatment.
A heat-sensitive liposome has been shown to triple the amount of an anti-cancer drug delivered to tumors in mice compared to other liposome-based methods. The liposome releases its cargo rapidly and effectively, increasing the functional concentration of the drug in the tumor.
Researchers found that blocking the interaction between two naturally occurring molecules restricts tumor growth and spread in mice. Inhibition of RAGE-amphoterin interaction decreased tumor cell growth, migration, and invasion without affecting angiogenesis.
Researchers at UCSF Comprehensive Cancer Center identified genetic regions that confer susceptibility and resistance to a human-like skin cancer in mice. The findings suggest that mouse studies may reveal genetic markers of susceptibility and resistance to cancer in humans, which could impact patient-specific treatment modalities.
A new MGH study has identified thrombospondin-2 (TSP-2) as a natural factor that inhibits tumor angiogenesis and growth in mouse models. The researchers found that TSP-2 completely stopped tumor growth when reintroduced into tumor cells, outperforming earlier anti-angiogenesis factors.
A mouse tumor model of neurofibromatosis type 1 has been developed, allowing researchers to study the genetic lesions that lead to malignant tumor formation. The study found that mutations in both NF-1 and p53 genes accelerate tumor growth, providing a potential target for new treatments.
Dr. Showe's laboratory is conducting research on CTCL, the most common primary T-cell lymphoma of the skin, using state-of-the-art robotic systems. The goal of her work is to give clinicians and pathologists new molecular tools to identify CTCL accurately in its early stage.
Researchers at Ohio University have discovered a unique retrovirus linked to skin tumors in walleye, which shares similarities with human cyclin D1. The study reveals that the presence of a specific mRNA precedes protein production, potentially leading to tumor cell death.
A new study found that shrinking tumors can reduce blood vessel pore sizes, making it harder for chemotherapy agents to reach their targets. Researchers recommend designing smaller, more agile drugs to overcome this challenge.
A new strategy to treat and prevent tumors has been developed by University of Pittsburgh researchers using dendritic cells. The approach effectively prevents tumor development in healthy mice and reduces tumors in 80% of mice with established tumors, significantly prolonging their survival.
Researchers have developed new 'green' materials derived from chlorophyll, which can be used to overcome limitations of photodynamic therapy (PDT) for treating bulky solid tumors. These materials can kill cancer cells in tissue culture and mice while minimizing side effects.
Researchers have discovered that GM-CSF, a cytokine produced by melanoma tumors, can stimulate the immune system to attack and eliminate tumor cells. Delivering GM-CSF directly to tumors may lead to effective treatment of advanced melanoma cases.
Cryosurgery has been used to treat prostate and skin cancers, but recently began treating advanced liver cancer. The procedure freezes tumors using liquid nitrogen, with Emory University Hospital as one of the few medical centers offering it.
Researchers found that captopril inhibited the growth of new blood vessels essential for tumor growth, potentially reducing cancer incidence and severity. The drug's mechanism may differ from its blood pressure-lowering effects.